The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women
Open accessAbstract
Women with polycystic ovary syndrome (PCOS) are insulin resistant, have insulin secretory defects, and are at high risk for glucose intolerance. We performed this study to determine the prevalence of glucose intolerance and parameters associated with risk for this in PCOS women. Two-hundred and fifty-four PCOS women, aged 14-44 yr, were prospectively evaluated at 2 centers, 1 urban and ethnically diverse (n = 110) and 1 rural and ethnically homogeneous (n = 144). The rural PCOS women were compared to 80 control women of similar weight, ethnicity, and age. A 75-g oral glucose challenge was administered after a 3-day 300-g carbohydrate diet and an overnight fast with 0 and 2 h blood samples for glucose levels. Diabetes was categorized according to WHO criteria. The prevalence of glucose intolerance was 31.1% impaired glucose intolerance (IGT) and 7.5% diabetes. In nonobese PCOS women (body mass index, <27 kg/m2), 10.3% IGT and 1.5% diabetes were found. The prevalence of glucose intolerance was significantly higher in PCOS vs. control women (chi2 = 7.0; P = 0.01; odds ratio = 2.76; 95% confidence interval = 1.23-6.57). Variables most associated with postchallenge glucose levels were fasting glucose levels (P < 0.0001), PCOS status (P = 0.002), waist/hip ratio (P = 0.01), and body mass index (P = 0.021). The American Diabetes Association criteria applied to fasting glucose significantly underdiagnosed diabetes compared to the WHO criteria (3.2% vs. 7.5%; chi2 = 4.7; P = 0.046; odds ratio = 2.48; 95% confidence interval = 1.01-6.69). We conclude that 1) PCOS women are at significantly increased risk for IGT and type 2 diabetes mellitus at all weights and at a young age; 2) these prevalence rates are similar in 2 different populations of PCOS women, suggesting that PCOS may be a more important risk factor than ethnicity or race for glucose intolerance in young women; and 3) the American Diabetes Association diabetes diagnostic criteria failed to detect a significant number of PCOS women with diabetes by postchallenge glucose values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As such, women with PCOS exhibit increased risk of impaired glucose tolerance and T2DM regardless of weight and age [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“Approximately 50–70% of women with PCOS have IR and hyperinsulinaemia [128], whereas many also present evidence of glucose intolerance [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“In women with PCOS, dysglycemia typically consists of impaired glucose tolerance [12], its prevalence being of almost 30% in both adult women [13] and affected adolescents [14].”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [12]
In the citing paper
“PCOS patients commonly have metabolic complications, such as type 2 diabetes, insulin resistance (IR), and adipose tissue dysfunction (7–9).”
From Circulating Adipokine Levels in Nonobese Women with Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis (2021) · cites this paper as [7]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“In PCOS, other novel CVD risk factors, premature cardiovascular dysfunction and subclinical CVD 29,30,83 have been noted and are related to IR and obesity. 84-89”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [85]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 1,101–1,200 of 1,388
Gupta, N., Radhakrishnan, G., Madhu, S., & Radhika, A. G. (2015) · Fertility Science and Research · doi:10.4103/2394-4285.180491 · Cited by 9
Legro, R. S. (2004) · Elsevier eBooks · doi:10.1016/b978-012444562-8/50030-6 · Cited by 9
Self-citationRing, M. R. (2017) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2017.02.012 · Cited by 11
Adrenal and Polycystic Ovary Syndrome
Çelik, Ö., & Yıldız, B. O. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108989831.008 · Cited by 9
An algorithm for treatment of infertile women with polycystic ovary syndrome
Kawwass, J. F., Loucks, T. L., & Berga, S. L. (2010) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2010.07.010 · Cited by 10
Biro, F. M. (2003) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200310000-00001 · Cited by 9
Fasting Insulin Pulsatile Secretion in Lean Women with Polycystic Ovary Syndrome
Grimmichová, T., Vrbíková, J., Matucha, P., Vondra, K., Veldhuis, P. P., & Johnson, M. (2008) · Physiological Research · doi:10.33549/physiolres.931493 · Cited by 9
Insulin-sensitising drugs for polycystic ovary syndrome
Tang, T. H., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub2 · Cited by 9
Lifestyle changes in women with Polycystic Ovary Syndrome
Moran, L., Hutchison, S. K., Norman, R. J., & Teede, H. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506 · Cited by 10
(2008) · Reproductive medicine and assisted reproductive techniques series · doi:10.3109/9781439807224.004 · Cited by 9
Farhan, M., Seyfi, A., Alnuaimi, A., Alamour, M., Alwarafi, S., Elastal, H., Nazir, M. H., Kamaraj, B., Nagarajan, H. D. P., Delianne, D., et al. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003217 · Cited by 12
Habib, S., Anwar, A., Hoda, F., Verma, R., Akhtar, M., & Najmi, A. K. (2021) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20214500 · Cited by 9
Patil, K., Naigaonkar, A., Hinduja, I. N., et al. (2023) · Reproductive Biology · doi:10.1016/j.repbio.2023.100787 · Cited by 8
Seneviratne, H., Lankeshwara, D., Wijeratne, S., Somasunderam, N., & Dn, A. (2009) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02360.x · Cited by 7
Tiongco, R. E., Cabrera, F. J., Clemente, B., Flake, C. C., Salunga, M. A., & Pineda-Cortel, M. R. (2019) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2018.12.002 · Cited by 8
Pereira-Eshraghi, C., Tao, R., Chiuzan, C. C., Zhang, Y., Shen, W., Lerner, J. P., Oberfield, S. E., & Sopher, A. B. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.01.008 · Cited by 8
Bhushan, R., & Sinha, P. (2022) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_147_21 · Cited by 8
Obesity in Polycystic Ovary Syndrome
Morán, C., Arriaga, M., Rodriguez, G., & Mor, S. (2012) · InTech eBooks · doi:10.5772/27774 · Cited by 9
Primary and Secondary Amenorrhea
Chiavaroli, V., D’Adamo, E., Diesse, L., de, T., Chiarelli, F., & Moh, A. (2011) · InTech eBooks · doi:10.5772/17675 · Cited by 9
Treatment strategies in PCOS patients
Weiss, J., Tauchert, S., Ludwig, A. K., & Diedrich, K. (2005) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(11)60393-3 · Cited by 8
Syndrome des ovaires polymicrokystiques
Robin, G., Proust-Richard, C., Jonard-Catteau, S., & Dewailly, D. (2007) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(07)35089-0 · Cited by 6
Xu, X., Lai, Y., Yang, G., Yang, M., Li, L., Zhang, Q., Liu, H., Zheng, H., & Zhu, D. (2016) · Medicine · doi:10.1097/md.0000000000005524 · Cited by 8
Sarkar, M. A., & Suzuki, A. (2020) · Clinical Liver Disease · doi:10.1002/cld.955 · Cited by 9
Metformin and polycystic ovary syndrome
Keleştimur, F., Ünlühızarcı, K., Bayram, F., et al. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.0945a.x · Cited by 8
Gut Hormones, Obesity, Polycystic Ovarian Syndrome, Malignancy, and Lipodystrophy Syndromes
Bloomgarden, Z. T. (2007) · Diabetes Care · doi:10.2337/dc07-zb07 · Cited by 8
Savastano, S., Orio, F., Palomba, S., Cascella, T., Manguso, F., Lupoli, G., Formisano, P., Lombardi, G., Colao, A. A. L., Bèguinot, F., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02924.x · Cited by 8
Ding, M., Zhu, X., Huang, Y., et al. (2025) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2025.103215 · Cited by 7
COMPLICATIONS OF PREGNANCY IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
Azizia, M., & Hardiman, P. J. (2011) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539511000088 · Cited by 7
Excess mortality in mothers of patients with polycystic ovary syndrome
Louwers, Y. V., Roest-Schalken, M. E., Kleefstra, N., van Lennep, J. E. R., van den Berg, M. H., Fauser, B. C. J. M., Bilo, H. J. G., Sijbrands, E. J. G., & Laven, J. S. E. (2014) · Human Reproduction · doi:10.1093/humrep/deu107 · Cited by 7
Obesity and type 2 diabetes in children and youth
KAUFMAN, F. R. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000235322.01047.86 · Cited by 6
Peroxiredoxin 4 levels in patients with PCOS and/or obesity
Gateva, A., Velikova, T. V., & Kamenov, Z. A. (2019) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2019.04.002 · Cited by 7
Polycystic Ovarian Syndrome: Impact on Adult and Fetal Health
Martini, A. E., & Healy, M. W. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000593 · Cited by 8
Gülümsek, E., Peköz, B. Ç., Koç, A. S., et al. (2020) · Ultrasound Quarterly · doi:10.1097/ruq.0000000000000537 · Cited by 7
Taşolar, H., Mete, T., Ballı, M., Altun, B., Çetın, M., Yüce, T., Taşolar, S., Otlu, Ö., Bayramoğlu, A., & Pekdemir, H. (2014) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12308 · Cited by 7
Polycystic Ovarian Syndrome, Biomarkers, and Metformin: Research, Risk, and Reality
Sattar, N. A., & Nelson, S. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2486 · Cited by 7
Sindrom polikistoznykh yaichnikov i metabolicheskiy sindrom
Dedov, I. I., & Бутрова, С. А. (2006) · Obesity and metabolism · doi:10.14341/2071-8713-4940 · Cited by 7
Polycystic Ovary Syndrome and Insulin Resistance: New Approaches to Management, including Exercise
Laredo, S., Hannah, M. E., Casper, R. F., Feig, D. S., Leiter, L. A., & Rodgers, C. D. (2001) · Journal SOGC · doi:10.1016/s0849-5831(16)31301-5 · Cited by 7
Lu, C., Liu, X., Wang, L., Jiang, N., Yu, J., Zhao, X., Hu, H., Zheng, S., Li, X., & Wang, G. (2016) · Oncotarget · doi:10.18632/oncotarget.13881 · Cited by 8
Insulin resistance in obese and lean women with polycystic ovarian syndrome
Jayashree, S., Shylaja, P., & Ajjammanavar, V. (2018) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20185150 · Cited by 7
Dmitrović, R., & Legro, R. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-400-1_11 · Cited by 7
Self-citationThe impact of insulin resistance on woman's health and potential treatment options
Lois, K. B., Valsamakis, G., Mastorakos, G. P., & Kumar, S. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05646.x · Cited by 7
Diabetes Issues in Women and Children
Bloomgarden, Z. T. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2457 · Cited by 6
Ruderman, N. B., & Shulman, G. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00044-7 · Cited by 7
Genetic contributions to glucose intolerance in polycystic ovary syndrome
Ehrmann, D. A. (2004) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)62106-2 · Cited by 7
Tinano, F. R., Machado, I. F. R., Latronico, A. C., & Gomes, L. G. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1681-24.2024 · Cited by 8
Soy Isoflavones and PCOS: Role in Hormonal and Metabolic Mechanisms
Dereń, K., Michońska, I., Dymek, A., Zielińska, M., & Łuszczki, E. (2025) · Applied Sciences · doi:10.3390/app15116198 · Cited by 6
Šumarac-Dumanović, M., Stamenković-Pejković, D., Jeremić, D., Dumanović, J., Mandić, V., Žarković, M., & Micić, D. (2022) · International Journal of Endocrinology · doi:10.1155/2022/6630498 · Cited by 7
Sziva, R. E., Kollarics, R., Pál, É., Bányai, B., Korsós-Novák, Á., Fontányi, Z., Magyar, P., Süli, A., Nádasy, G. L., Ács, N., et al. (2025) · Nutrients · doi:10.3390/nu17020201 · Cited by 6
Polycystic ovary syndrome: Challenges in adolescence
Oliveira, A. B. F. D., Sampaio, B., Teixeira, A., Castro-Correia, C., Fontoura, M., & Medina, J. L. (2010) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.04.007 · Cited by 6
Ghatnatti, V., Patil, S., & Kour, H. (2022) · APIK Journal of Internal Medicine · doi:10.4103/ajim.ajim_117_20 · Cited by 7
Kataoka, J., Stener‐Victorin, E., Schmidt, J., & Larsson, I. (2024) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14867 · Cited by 6
Rare Variation in LMNA Underlies Polycystic Ovary Syndrome Pathogenesis in 2 Independent Cohorts
Bauer, R., Parker, C., Gorsic, L. K., Hayes, M. G., Kunselman, A. R., Legro, R. S., Welt, C. K., & Urbanek, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae761 · Cited by 6
Self-citationJaved, A., Kumar, S., Simmons, P. S., & Lteif, A. N. (2015) · Hormone Research in Paediatrics · doi:10.1159/000435883 · Cited by 6
Resistencia a la insulina, obesidad y síndrome metabólico en el síndrome del ovario poliquístico
Gambineri, A., & Pasquali, R. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71168-8 · Cited by 6
Polycystic Ovary Syndrome: A Review of Current Knowledge
DuRant, E., & Leslie, N. S. (2007) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2007.01.018 · Cited by 6
Thethi, T. K., Katalenich, B., Nagireddy, P., Chabbra, P., Kuhadiya, N. D., & Fonseca, V. A. (2015) · Endocrine Practice · doi:10.4158/ep14396.ra · Cited by 5
Can adiponectin predict abnormal glucose tolerance in Thai women with polycystic ovary syndrome?
Weerakiet, S., Tingthanatikul, Y., Boonnag, P., Wansumrith, S., Rattanasiri, S., & Leelaphiwat, S. (2008) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2007.00704.x · Cited by 6
Gazi, E., Gencer, M., Hancı, V., Temız, A., Altun, B., Barutçu, A., Gungor, A. N. C., Hacıvelioğlu, S., Uysal, A., & Çölkesen, Y. (2015) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2015-046 · Cited by 6
Diabetes Mellitus in Older Women
Lodhi, T. I. (2021) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2021.06.003 · Cited by 7
Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
Bellanger, S., Battista, M., & Baillargeon, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_7 · Cited by 5
Association of calpain 10 gene UCSNP-43 polymorphism (rs3792267) with polycystic ovarian syndrome
Thathapudi, S., Erukkambattu, J., Hasan, Q. A., Addepally, U., & Kodati, V. (2015) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20150452 · Cited by 6
Metabolic and cardiovascular effects of ghrelin
Кириенкова, Е. В., Litvinova, L. S., Seledtsov, V. I., et al. (2012) · Obesity and metabolism · doi:10.14341/2071-8713-5048 · Cited by 6
Tsaltas, T. T., & Stokes, M. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316084380.029 · Cited by 7
Effects of in utero androgen excess and metformin treatment on hepatic functions
Abruzzese, G. A., Heber, M. F., Ferrer, M. J., Ferreira, S. R., Silva, A. F., & Motta, A. B. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.03.006 · Cited by 6
Ruderman, N. B., & Shulman, G. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00043-3 · Cited by 7
Síndrome de ovario poliquístico (SOP) y embarazo: Experiencia clínica
Villarroel, A. C., Echiburú, B., Riesco, V., Maliqueo, M. A., Cárcamo, M., Hitschfeld, C., Sánchez, F., del Solar, M. P., & Sir‐Petermann, T. (2007) · Revista médica de Chile · doi:10.4067/s0034-98872007001200005 · Cited by 6
Do Cardiovascular Risk Factors in Polycystic Ovarian Syndrome Result in More Cardiovascular Events?
Guzick, D. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0288 · Cited by 6
Overview of Long-Term Morbidity and Economic Cost of the Polycystic Ovary Syndrome
Azziz, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_32 · Cited by 6
Retinol‐binding protein in nonobese women with polycystic ovary syndrome
Lee, J., Im, J., Lee, D., Lee, H. C., & Shim, J. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03098.x · Cited by 6
Danish, R. K., & West, B. (2005) · Diabetes Spectrum · doi:10.2337/diaspect.18.4.229 · Cited by 6
Insulin resistance and insulin secretion in childhood and adolescence
Arslanian, S. A. (2003) · CRC Press eBooks · doi:10.3109/9780203633120-7 · Cited by 6
The 6th Annual World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2009) · Diabetes Care · doi:10.2337/dc09-zb11 · Cited by 6
Hyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome
Barnes, R. B., Ehrmann, D. A., & Rosenfield, R. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00132-5 · Cited by 6
Androgen Excess Disorders in Women
Legro, R. S. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-388-0_7 · Cited by 7
Self-citationMaternal polycystic ovarian syndrome and offspring psychopathology and neurodevelopment
Kahn, L. G., Hipwell, A. E., Charifson, M., Ling, R., Cajachagua‐Torres, K. N., & Ghassabian, A. (2025) · Human Reproduction · doi:10.1093/humrep/deaf079 · Cited by 6
Assessment of Symptoms and Diet Intake in Young Adult with Polycystic Ovary Syndrome (PCOS)
George, S., & Alex, A. (2021) · Journal of scientific research · doi:10.37398/jsr.2021.650415 · Cited by 5
Tűű, L., Nas, K., Török, M., & Várbíró, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030838 · Cited by 7
Polycystic ovarian syndrome and insulin resistance: a North Indian study
Agarwal, N., Gangopadhyay, S., Koch, N., Gupta, A., Batra, A., & Kabi, B. C. (2015) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20150139 · Cited by 5
Diabetes advice for women with polycystic ovary syndrome: prevention, prevention, prevention
Mani, H., Khunti, K., Levy, M. J., & Davies, M. J. (2013) · Diabetes Management · doi:10.2217/dmt.13.54 · Cited by 5
Roessler, K. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803634-1.00021-2 · Cited by 5
Indu, N. R., Hiremath, P. B., Sanyal, U., et al. (2018) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20183793 · Cited by 5
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00022-6 · Cited by 4
Serum CCL 18 levels in women with polycystic ovarian syndrome
Suryanarayana, K., Sam, J., Dharmalingam, M., Kalra, P., & Selvan, C. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_650_19 · Cited by 5
Gojnić-Dugalić, M., Jeremić, K., Stefanović, A., Jotić, A., Lalic, N. M., Vrzić-Petronijević, S., Petronijevic, M. A., Milicic, T. J., Lukić, L., Todorović, J., et al. (2021) · Medicine · doi:10.1097/md.0000000000027232 · Cited by 5
Azziz, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_1 · Cited by 5
Heald, A. H., Livingston, M. A., Holland, D., Robinson, J. C., Moreno, G. Y., Donnahey, G., Duff, C. J., Wu, P., & Fryer, A. A. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.13046 · Cited by 5
Conservative Management of Gynecologic Diseases
Diamanti‐Kandarakis, E., & KANDARAKIS, H. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.035 · Cited by 5
Pontes, A. G., Rehme, M. F. B., Micussi, M. T. A. B. C., Maranhão, T. M. D. O., Pimenta, W. P., de Carvalho, L. R., & Pontes, A. (2012) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032012000300007 · Cited by 5
Walch, K., Grimm, C., Nagele, F., Huber, J. C., Wölfler, M. M., Vytiska‐Binstorfer, E., Unfried, G., & Hefler, L. (2006) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340500342938 · Cited by 5
Cheang, K. I., Essah, P. A., & Nestler, J. E. (2004) · HORMONES · doi:10.14310/horm.2002.11133 · Cited by 5
Fetal programming of polycystic ovary syndrome
Abbott, D. H., Bruns, C. M., Barnett, D. K., & Dumesic, D. A. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545191.016 · Cited by 5
Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_33 · Cited by 5
Altemimi, M. T., musa, A. K., & Mansour, A. A. (2021) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v13i2.1431 · Cited by 4
Krstevska, B., Mishevska, S. J., Nakova, V. V., & Serafimoski, V. (2021) · PRILOZI · doi:10.2478/prilozi-2021-0022 · Cited by 4
The main directions and prospects in polycystic ovary syndrome treatment
Наримановна, У. А., Egorova, E. A., Yelisheva, E. A., Beitullaev, А. М., & Koryanova, K. N. (2021) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20210602 · Cited by 4
Innovations in surgery to perform an ovarian drilling
Jegaden, M., Rullaud, M., Debras, É., Pourcelot, A.-G., Capmas, P., & Fernandez, H. (2022) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2022.102499 · Cited by 4
Defining prediabetes in polycystic ovarian syndrome
Trolice, M. P. (2011) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2011.12008 · Cited by 5
Yan, M., Liang, G.-Y., Xia, B.-R., Liu, D.-Y., Kong, D., & Jin, X. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.09.001 · Cited by 4
Ramanand, S. J., Ramanand, J. B., Raparti, G., Ghanghas, R. R., Halasawadekar, N. R., Patil, P. T., Pawar, M., & Shinde, M. (2014) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.5455/2320-1770.ijrcog20140324 · Cited by 4
Serafi, T. I. E., Awad, M. M., Eldeen, L. A. T., et al. (2013) · Egyptian Liver Journal · doi:10.1097/01.elx.0000427103.05494.6c · Cited by 4
Metadata
- Authors
- Legro, R. S.
- Affiliations
- Pennsylvania State University (US)
- ORCID
- Legro, R. S.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-01-01
- Volume
- 84
- Issue
- 1
- Pages
- 165-169
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2096126402
- Cited by
- 1,743
- References
- 0
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 36 · 2023: 24 · 2022: 50 · 2021: 64 · 2020: 54 · 2019: 42 · 2018: 43 · 2017: 66 · 2016: 59 · 2015: 88 · 2014: 81 · 2013: 73 · 2012: 84
- FWCI
- 44.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K08 HD-O118, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, type 2 diabetes, impaired glucose tolerance, insulin resistance, insulin secretion, diabetes risk factors, prevalence, fasting blood glucose, waist-to-hip ratio, body mass index, ethnic differences, diagnostic criteria, underdiagnosis, oral glucose tolerance test, young women, obesity
- MeSH terms
- Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Prospective Studies, Risk, Body Mass Index, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
